Congo vs Guatemala: The number of people with susceptibility test result for rifampicin
Congo
2,015
in 2021
Guatemala
2,022
in 2021
Congo rank
47th
Guatemala rank
46th
The number of people with susceptibility test result for rifampicin over time
- Congo
- Guatemala
How they compare
Guatemala currently reports 2,022 against 2,015 in Congo, a difference of 7.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Guatemala ahead.
Congo ranks 47th and Guatemala ranks 46th of 155 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Guatemala in 1.
Head to head by decade
| Decade | Congo | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 621 | 1,126 | 505 | Guatemala |
| 2020s | 3,055 | 1,352 | 1,703 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo or Guatemala?
- Guatemala, at 2,022 against 2,015 in Congo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo and Guatemala?
- 7, with Guatemala ahead.
- How many years of comparable data are there for Congo and Guatemala?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo and Guatemala rank globally for the number of people with susceptibility test result for rifampicin?
- Congo ranks 47th and Guatemala ranks 46th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.